4Christiansen JS,Vaz JA,Metelko Z,et al.Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin with low risk of hypoglycaemia in patients with type 2 diabetes.Diabetes Obes Metab,2003,5(6):446 ～ 454.
5McSorley PT,Bell PM,Jacobsen LV,et al.Twice daily biphasic insulin aspart 30 versus biphasic human insulin 30:a double blind crossover study in adults with type 2 diabetes mellitus.Clin Ther,2002,24(4):530 ～ 539.
二级参考文献16
1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.
7Turner RC,Cull CA,Frighi V.Clycemic controlwith diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus:progressive requirement formul-tiple therapies (UKPDS)[J].AMA,1999,281(21):2005-2012.
8Christiansen JS,Vaz JA,Metelko Z,et al.Twicedaily biphasic insulin aspart improves post-prandial glycaemic control more effectively than twice daily NPH insulin with low risk of hypoglycaemia in patients with type 2 diabetes[J].Diabetes Obes Metab,2003,5(6):446-454.
9Lindholm A,Jacobsen LV.Clincal pharmaco-kinetics and pharmacodynamics of insulin aspart[J].Clin Pharmacokinet,2001,40:641.
10Christiansen JS,Vaz JA,Metelko Z,et al.Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin with low risk of hypoglycaemia in patients with type 2 diabetes.Diabetes Obes Metab,2003,5(6):446-454
